Prevent Blindness, the nation’s oldest volunteer eye health and safety organization, has launched a unique new resource, “GuideMe”, designed for those who have been diagnosed with Age-related Macular Degeneration (AMD) or Diabetic Macular Edema (DME). The intent of the GuideMe books is to simulate as accurately as possible a post-diagnosis consultation with a doctor or therapist. They [Read More]
News
Ocata's Stem Cell Trials Entering Phase 2
Results from First Cohort Expected in the Second Quarter of 2016 Acucela (formerly Ocata) has announced that the first patient has been enrolled in the company’s Phase 2 clinical trial using Ocata’s proprietary RPE cells in patients with atrophic (dry) age-related macular degeneration (AMD). The purpose of the trial is to evaluate safety and explore efficacy as compared [Read More]
Long-term Treatment for Wet AMD Enters Phase 2 Trials
Neurotech Pharmaceuticals, Inc. has announced that they have enrolled the first patient in their multicenter Phase 2 clinical trial of NT-503 Encapsulated Cell Therapy (ECT) for the long-term treatment of wet macular degeneration (AMD). NT-503 is a unique vascular endothelial growth factor (VEGF) receptor protein continuously produced by Neurotech’s versatile ECT implant. “This landmark proof-of-concept [Read More]
New Book On Eye Nutrition Answers Common Questions
Leading nutrition expert Jeffrey Anshel, OD, FAAO, has just published a new book titled “What You Must Know about Food and Supplements for Optimal Vision Care.” It is a practical guide to diets, supplements and lifestyles for peak ocular health, with excellent information about how to integrate supplements with mainstream medical treatments whenever appropriate. Dr. [Read More]
Preventative Eye Care Should Be At The Political Forefront
Guest Editorial by Ellen Troyer, MT, MA CEO, Biosyntrx The Affordable Care Act (ACA) doesn’t pay for Medicare and Medicaid routine eye exams for disease prevention but it does cover diagnosed disease identified in self-pay routine eye exams. This leaves an ever-growing segment of the adult US population with limited access to eye care professionals, [Read More]